en
Feedback
Respiratory Updates

Respiratory Updates

Open in Telegram

🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Show more

📈 Analytical overview of Telegram channel Respiratory Updates

Channel Respiratory Updates (@respiratoryupdates) in the English language segment is an active participant. Currently, the community unites 19 484 subscribers, ranking 1 176 in the Medicine category and 17 179 in the Iran region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 19 484 subscribers.

According to the latest data from 30 August, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 484 over the last 30 days and by 8 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 12.30%. Within the first 24 hours after publication, content typically collects 5.50% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 2 394 views. Within the first day, a publication typically gains 1 070 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 6.
  • Thematic interests: Content is focused on key topics such as patient, guideline, edit, reader, society.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Thanks to the high frequency of updates (latest data received on 31 August, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

19 484
Subscribers
+824 hours
+1117 days
+48430 days
Attracting Subscribers
August '26
August '26
+505
in 1 channels
July '26
+584
in 0 channels
Get PRO
June '26
+565
in 0 channels
Get PRO
May '26
+718
in 0 channels
Get PRO
April '26
+515
in 0 channels
Get PRO
March '26
+196
in 0 channels
Get PRO
February '26
+185
in 0 channels
Get PRO
January '26
+238
in 1 channels
Get PRO
December '25
+234
in 0 channels
Get PRO
November '25
+286
in 2 channels
Get PRO
October '25
+335
in 0 channels
Get PRO
September '25
+408
in 0 channels
Get PRO
August '25
+389
in 1 channels
Get PRO
July '25
+429
in 0 channels
Get PRO
June '25
+420
in 4 channels
Get PRO
May '25
+416
in 0 channels
Get PRO
April '25
+457
in 1 channels
Get PRO
March '25
+496
in 1 channels
Get PRO
February '25
+548
in 1 channels
Get PRO
January '25
+981
in 1 channels
Get PRO
December '24
+1 335
in 1 channels
Get PRO
November '24
+1 714
in 2 channels
Get PRO
October '24
+1 758
in 1 channels
Get PRO
September '24
+1 250
in 1 channels
Get PRO
August '24
+1 052
in 2 channels
Get PRO
July '24
+418
in 5 channels
Get PRO
June '24
+520
in 3 channels
Get PRO
May '24
+368
in 2 channels
Get PRO
April '24
+365
in 2 channels
Get PRO
March '24
+385
in 2 channels
Get PRO
February '24
+437
in 2 channels
Get PRO
January '24
+704
in 3 channels
Get PRO
December '23
+683
in 1 channels
Date
Subscriber Growth
Mentions
Channels
31 August+17
30 August+8
29 August+20
28 August+25
27 August+13
26 August+14
25 August+12
24 August+19
23 August+15
22 August+13
21 August+16
20 August+22
19 August+17
18 August+12
17 August+19
16 August+17
15 August+21
14 August+15
13 August+12
12 August+25
11 August+34
10 August+10
09 August+14
08 August+5
07 August+14
06 August+14
05 August+17
04 August+18
03 August+17
02 August+18
01 August+12
Channel Posts
+1
🔴 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement

2
IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf
2 450
3
SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava Recent updates in advanced pulmonary sarcoidosis Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295
4 995
4
Respiratory Medicine Volume 255, April–May 2026, 108751 Original Research The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial https://doi.org/10.1016/j.rmed.2026.108751
4 388
5
Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z
4 453
6
Review Article Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials the Nebulized Heparin Study Group Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161
4 661
7
Annals of intensive care.pdf
4 784
8
American Journal of Kidney Diseases Available online 3 July 2026 In Press, Journal Pre-proof Perspective Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies https://doi.org/10.1053/j.ajkd.2026.03.048
4 833
9
ICU Nutrition Q&A.pdf
4 837
10
خلاصه وازوپرسو و اینوتروپ #Critical_Care
خلاصه وازوپرسو و اینوتروپ #Critical_Care
5 050
11
آقای ۶۲ ساله با تشخیص شوک سپتیک ناشی از پنومونی، در icu . بیمار تحت رژیم درمانی با نوراپی‌نفرین ۳۶ میکروگرم در دقیقه قرار دارد. در آخرین بررسی: · MAP = ۵۵ U/O = ۰.۳ cc/kh/ht · لاکتات سرم = ۴.۲ (روند نزولی ندارد) · CRT = ۴ بهترین اقدام؟
1
12
Feature Article Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072
5 705
13
+2
The Lancet Respiratory Medicine Available online 5 June 2026 In Press, Corrected Proof Position Paper Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement https://doi.org/10.1016/S2213-2600(26)00094-9
6 903
14
Critical_Care_2025 مبادرة خير.pdf
6 369
15
+1
No text...
3 364
16
+1
No text...
3 330
17
The new ACC/AHA 2026 guidelines of pulmonary embolism
3 276
18
creager_et_al_2026_2026_aha_acc_accp_acep_chest_sc_260219_225656.pdf
4 146
19
No text...
5 051
20
The Lancet Respiratory Medicine Available online 12 February 2026 In Press, Corrected Proof Articles Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials KALOS and LOGOS study investigators † https://doi.org/10.1016/S2213-2600(25)00457-6
5 027